2k9e
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | {{Seed}} | |
+ | [[Image:2k9e.jpg|left|200px]] | ||
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_2k9e", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_2k9e| PDB=2k9e | SCENE= }} | ||
- | + | ===NMR Solution Structure for ShK-192: A Potent KV1.3-Specific Immunosuppressive Polypeptide=== | |
- | Description: NMR Solution Structure for ShK-192: A Potent KV1.3-Specific Immunosuppressive Polypeptide | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | <!-- |
+ | The line below this paragraph, {{ABSTRACT_PUBMED_19122005}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 19122005 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_19122005}} | ||
+ | |||
+ | ==About this Structure== | ||
+ | 2K9E is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2K9E OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:19122005</ref><references group="xtra"/> | ||
+ | [[Category: Galea, C A.]] | ||
+ | [[Category: Ionic channel inhibitor]] | ||
+ | [[Category: Nematocyst]] | ||
+ | [[Category: Neurotoxin]] | ||
+ | [[Category: Potassium channel inhibitor]] | ||
+ | [[Category: Protein]] | ||
+ | [[Category: Secreted]] | ||
+ | [[Category: Toxin]] | ||
+ | |||
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 21 10:35:59 2009'' |
Revision as of 08:36, 21 January 2009
NMR Solution Structure for ShK-192: A Potent KV1.3-Specific Immunosuppressive Polypeptide
Template:ABSTRACT PUBMED 19122005
About this Structure
2K9E is a 1 chain structure. Full crystallographic information is available from OCA.
Reference
- Pennington MW, Beeton C, Galea CA, Smith BJ, Chi V, Monaghan KP, Garcia A, Rangaraju S, Giuffrida A, Plank D, Crossley G, Nugent D, Khaytin I, Lefievre Y, Peshenko I, Dixon C, Chauhan S, Orzel A, Inoue T, Hu X, Moore RV, Norton RS, Chandy KG. Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes. Mol Pharmacol. 2009 Apr;75(4):762-73. Epub 2009 Jan 2. PMID:19122005 doi:10.1124/mol.108.052704
Page seeded by OCA on Wed Jan 21 10:35:59 2009